{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:17:54Z","timestamp":1778890674975,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.prp.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T23:05:32Z","timestamp":1530140732000},"page":"1504-1509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation"],"prefix":"10.1016","volume":"214","author":[{"given":"Yoshitane","family":"Tsukamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Futani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kumanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2033-3908","authenticated-orcid":false,"given":"Shohei","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Yoshiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2018.06.015_bib0005","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","first-page":"321","article-title":"Giant cell tumour of bone","author":"Athanasou","year":"2013"},{"key":"10.1016\/j.prp.2018.06.015_bib0010","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone","volume":"18","author":"Branstetter","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2018.06.015_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0000000000000506","article-title":"Denosumab-treated giant cell tumor of bone exhibits morphologic overlap with malignant giant cell tumor of bone","volume":"40","author":"Wojcik","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0020","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2018.06.015_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics","volume":"1","author":"Presneau","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.prp.2018.06.015_bib0030","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/cas.12413","article-title":"Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone","volume":"105","author":"Kato Kaneko","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2018.06.015_bib0040","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/cncr.11359","article-title":"Malignancy in giant cell tumor of bone","volume":"97","author":"Bertoni","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2018.06.015_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humpath.2017.11.020","article-title":"Diagnostic utility of histone H3.3G34 W, G34R, and G34 V mutant-specific antibodies for giant cell tumors of bone","volume":"73","author":"Yamamoto","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ehpc.2015.12.001","article-title":"A rare case of Ewing sarcoma with elevated plasma pro-gastrin-releasing peptide (proGRP) level","volume":"6","author":"Tsukamoto","year":"2016","journal-title":"Hum. Pathol. Case Rep."},{"key":"10.1016\/j.prp.2018.06.015_bib0055","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.prp.2017.06.008","article-title":"Primary undifferentiated small round cell sarcoma of the deep abdominal wall with a novel variant of t(10;19) CIC-DUX4 gene fusion","volume":"213","author":"Tsukamoto","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2018.06.015_bib0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ng.1107","article-title":"A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion","volume":"44","author":"Pierron","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2018.06.015_bib0065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humpath.2017.08.033","article-title":"Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone","volume":"68","author":"Righi","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0075","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/gcc.22469","article-title":"Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone","volume":"56","author":"Ogura","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2018.06.015_bib0080","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","first-page":"106","article-title":"Giant cell tumour of soft tissues","author":"Oliveira","year":"2013"},{"key":"10.1016\/j.prp.2018.06.015_bib0085","first-page":"894","article-title":"Soft tissue giant cell tumor of low malignant potential: a proposal for reclassification of malignant giant cell tumor of soft parts","volume":"12","author":"Folpe","year":"1999","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00000478-200003000-00007","article-title":"Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors","volume":"24","author":"O\u2019Connell","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/modpathol.2016.236","article-title":"Giant cell tumor of soft tissue is genetically distinct from its bone counterpart","volume":"30","author":"Lee","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/his.13249","article-title":"Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart","volume":"71","author":"Mancini","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2018.06.015_bib0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0b013e31802b86f8","article-title":"Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides","volume":"31","author":"Cupp","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.06.015_bib0110","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","first-page":"100","article-title":"Tenosynovial giant cell tumour, localized type & Tenosynovial giant cell tumour, diffuse type","author":"de Saint Aubain Somerhausen","year":"2013"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818304758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818304758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T19:02:02Z","timestamp":1535137322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818304758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0344033818304758"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2018.06.015","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}